Department of Biomedical Science, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Department of Parasitology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Mol Biochem Parasitol. 2021 Jul;244:111390. doi: 10.1016/j.molbiopara.2021.111390. Epub 2021 Jun 1.
The present study aimed to examine the genetic diversity of human malaria parasites (i.e., P. falciparum, P. vivax and P. knowlesi) in Malaysia and southern Thailand targeting the 19-kDa C-terminal region of Merozoite Surface Protein-1 (MSP-1). This region is essential for the recognition and invasion of erythrocytes and it is considered one of the leading candidates for asexual blood stage vaccines. However, the genetic data of MSP-1 among human malaria parasites in Malaysia is limited and there is also a need to update the current sequence diversity of this gene region among the Thailand isolates. In this study, genomic DNA was extracted from 384 microscopy-positive blood samples collected from patients who attended the hospitals or clinics in Malaysia and malaria clinics in Thailand from the year 2008 to 2016. The MSP-1 was amplified using PCR followed by bidirectional sequencing. DNA sequences identified in the present study were subjected to Median-joining network analysis with sequences of MSP-1 obtained from GenBank. DNA sequence analysis revealed that PfMSP-1 of Malaysian and Thailand isolates was not genetically conserved as high number of haplotypes were detected and positive selection was prevalent in PfMSP-1, hence questioning its suitability to be used as a vaccine candidate. A novel haplotype (Q/TNG/L) was also detected in Thailand P. falciparum isolate. In contrast, PvMSP-1 was highly conserved, however for the first time, a non-synonymous substitution (A1657S) was reported among Malaysian isolates. As for PkMSP-1, the presence of purifying selection and low nucleotide diversity indicated that it might be a potential vaccine target for P. knowlesi.
本研究旨在针对恶性疟原虫(Pf)、间日疟原虫(Pv)和诺氏疟原虫(Pk)的 19kDa 羧基末端区域(MSP-1),研究马来西亚和泰国南部地区人类疟原虫的遗传多样性。该区域对于裂殖子识别和入侵红细胞至关重要,被认为是无性血期疫苗的主要候选区域之一。然而,马来西亚人类疟原虫 MSP-1 的遗传数据有限,并且还需要更新泰国分离株中该基因区域的当前序列多样性。本研究从 2008 年至 2016 年,从马来西亚的医院和诊所以及泰国的疟疾诊所采集的 384 份显微镜阳性血样中提取基因组 DNA。使用 PCR 扩增 MSP-1,然后进行双向测序。将本研究中鉴定的 DNA 序列与从 GenBank 获得的 MSP-1 序列进行中位数连接网络分析。DNA 序列分析显示,马来西亚和泰国分离株的 PfMSP-1 遗传上并不保守,因为检测到大量单倍型,并且 PfMSP-1 中存在正选择,因此质疑其作为疫苗候选物的适用性。还在泰国恶性疟原虫分离株中检测到一种新的单倍型(Q/TNG/L)。相比之下,PvMSP-1 高度保守,但首次在马来西亚分离株中报告了非同义突变(A1657S)。对于 PkMSP-1,纯化选择和低核苷酸多样性的存在表明它可能是诺氏疟原虫的潜在疫苗靶标。